Status:
COMPLETED
Observational Study Assessing Chronic Hepatitis C Management in Clinical Practice in Italy (Study P05488 AM1)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Hepatitis C
Hepatitis C, Chronic
Eligibility:
All Genders
18+ years
Brief Summary
The goal of this study is to elucidate the reasons why patients with chronic hepatitis C (CHC) would not be considered eligible for antiviral treatment. The study is conducted in common clinical pract...
Detailed Description
Probability sampling: Consecutive adult patients with chronic hepatitis C in clinical practice at approximately 54 sites in Italy will be included in the study. The decision as to treatment choice fal...
Eligibility Criteria
Inclusion
- Willingness to sign an Informed Consent
- Male and female patients \>=18 years of age with Chronic Hepatitis C
- Not previously treated with Peg-Interferons
- Positive for serum hepatitis C virus (HCV)-ribonucleic acid (RNA)
Exclusion
- Previous treatment with peginterferon
- Participation in a therapeutic Good Clinical Practice (GCP) clinical study within 30 days prior to study start
Key Trial Info
Start Date :
July 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2011
Estimated Enrollment :
1128 Patients enrolled
Trial Details
Trial ID
NCT00724451
Start Date
July 1 2008
End Date
October 1 2011
Last Update
September 25 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.